GLP-3RT 20MG
$180.00
GLP-3RT is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor.
Research:
GLP-3RT Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
Description
GLP-3RT 20MG is a GGG tri-agonist that targets GLP-1, GIP receptors, and also uniquely activates the glucagon receptor. By activating the GLP-1, GIP, and glucagon receptors, it offers a comprehensive approach to metabolic health
Clinical Data:
GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial
GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)
GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial
Product Care:
Store in a cool, dry place away from light. If Constituted, Please Refrigerate. For longer term storage, freezing at -20°C is recommended to maintain integrity.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Product Note:
All products are shipped in lyphollized or powder form and must be reconstituted to a liquid for research and testing. We are unable to provide any dosing instructions, however all products should be considered pharmaceutical grade.
